Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

Autor: Lavaud P; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Gravis G; Institut Paoli Calmette, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Marseille University, UM 105, F-13284, Marseille, France., Foulon S; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France., Joly F; Oncology Department, Centre François Baclesse, Caen, France., Oudard S; Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France., Priou F; Department of Oncology, Centre hospitalier départemental Les Oudairies, La Roche-sur-Yon, France., Latorzeff I; Department of Radiotherapy, Groupe ONCORAD Garonne and Clinique Pasteur, Toulouse, France., Mourey L; Department of Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Soulié M; Department of Urology, Andrology and Transplantation, Centre Hospitalier Universitaire Toulouse-Rangueil, Toulouse, France., Delva R; Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France., Krakowski I; Department of Oncology, Centre Bergonié, Bordeaux, France., Laguerre B; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Théodore C; Department of Medical Oncology, Hopital Foch, Suresnes, France., Ferrero JM; Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France., Beuzeboc P; Department of Medical Oncology, Curie Institute, Paris, France., Habibian M; R&D Unicancer, Paris, France., Rolland F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France., Deplanque G; Department of Medical Oncology, Hopital Riviera-Chablais, Vaud-Valais - Vevey, Switzerland., Pouessel D; Department of Medical Oncology, Institut Claudius Rigaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France., Zanetta S; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France., Berdah JF; Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France., Dauba J; Medical Oncology Department, Hôpital Layné, Mont de Marsan, France., Baciuchka M; Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France., Platini C; Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France., Linassier C; Medical Oncology Department, Hôpital Bretonneau, Tours, France., Tubiana-Mathieu N; Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France., Machiels JP; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium., Kouri CE; Medical Oncology Department, Centre Catherine de Sienne, Nantes, France., Ravaud A; Medical Oncology Department, Hôpital Saint-André, Bordeaux, France., Suc E; Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France., Eymard JC; Medical Oncology Department, Institut Jean Godinot, Reims, France., Hasbini A; Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint Brieuc, France., Bousquet G; Medical Oncology Department, Hôpital Avicenne, Bobigny, France., Culine S; Medical Oncology Department, Hôpital Saint Louis, Paris, France., Boher JM; Department of Clinical Research and Investigation, Biostatistics, and Methodology Unit, Institut Paoli Calmettes, Marseille, France., Tergemina-Clain G; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France., Legoupil C; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France., Fizazi K; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.

Publikováno v: European urology [Eur Urol] 2018 May; Vol. 73 (5), pp. 696-703. Date of Electronic Publication: 2017 Oct 23.

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.

Autor: Vallée A; Department of Biochemistry, Nantes University Hospital, France., Marcq M, Bizieux A, Kouri CE, Lacroix H, Bennouna J, Douillard JY, Denis MG

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2013 Nov; Vol. 82 (2), pp. 373-4. Date of Electronic Publication: 2013 Aug 19.

Use of protamine to augment adenovirus-mediated cancer gene therapy.

Autor: Lanuti M; Department of Surgery, Thoracic Oncology Research Laboratory, Philadelphia, PA, USA., Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S

Publikováno v: Gene therapy [Gene Ther] 1999 Sep; Vol. 6 (9), pp. 1600-10.